📰 Agent Capital News
Page 4 - Agent Capital News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Agent Capital. Real-time updates on events, politics, business and more.
November 7, 2022
Investegate announcements from Zenas BioPharma, Zenas BioPharma Secures $118 Million to Advance Its Broad Pipeline of Autoimmune Disease Therapeutics
November 7, 2022
Proceeds to fund global Phase 3 registration program for the company's lead product candidate, Obexelimab, and support the clinical development of other pipeline programsSeries B equity financing led by
October 3, 2022
Today the king and queen consort will attend their first joint public engagement, marking the end of the royal period of mourning for the late queen. the couple will visit dunfermline in fife as part of the celebrations to mark its new city status. our scotland correspondent lorna gordon is in dunfermline for us. what can we expect today? it is a bi da what can we expect today? it is a big day for— what can we expect today? it is a big day for dunfermline, - what can we expect today? it is a i...
September 25, 2022
The combined company will operate under Carisma's name, and will work on advancing Carisma’s proprietary cell therapy platform.
September 21, 2022
The firm will use a biomarker strategy in its Phase I/II clinical trial to evaluate responses to therapy and inform future patient selection.
August 23, 2022
Press release content from PR Newswire. The AP news staff was not involved in its creation.
June 21, 2022
FinSMEs is the financial news site dedicated to covering venture capital, private equity, and merger and acquisition deals in real time!
June 14, 2022
ImCheck Therapeutics aims to broaden the reach of cancer immunotherapy with antibody drugs that activate a rare but powerful type of immune cell called gamma delta T cells. The biotech has unveiled €96 million to advance its pipeline, including a lead candidate in development for both liquid and solid tumors.